A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative)

Hope S Rugo1 University of California-San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA

Aditya Bardia2 Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA

Frederik Marmé3 Medical Faculty Mannheim, Heidelberg University, Department of Obstetrics & Gynaecology, Mannheim, Germany

Javier Cortés4 International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain/Medica Scientia Innovation Research (MedSIR), Barcelona, Spain;5 Universidad Europea de Madrid, Faculty of Biomedical & Health Sciences, Madrid, Spain

Peter Schmid6 Barts Cancer Institute, Queen Mary University of London, London, UK

Patricia A Spears7 Patient author, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC

Sara M Tolaney8 Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

show all

A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative)

Figures & data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date